FDA data Registry peer set 1 peer

Alternatives to ceftolozane/tazobactam

1 same-class SPL records vs ceftolozane/tazobactam - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Zerbaxa

Cephalosporin / Beta-Lactamase Inhibitor Prescription 1 alternative found

About ceftolozane/tazobactam

Zerbaxa is a combination of two antibiotics, ceftolozane and tazobactam. It fights bacterial infections in your body.

Used for: Zerbaxa treats complicated infections in the stomach area and urinary tract. This includes kidney infections. It also treats pneumonia that you get while in the hospital or from being on a ventilator. Zerbaxa should only be used to treat infections that are proven or strongly suspected to be caused by bacteria.

1 Cephalosporin / Beta-Lactamase Inhibitor peers (wide set)

Compare ceftolozane/tazobactam vs ceftazidime/avibactam side-by-side →

ceftolozane/tazobactam vs ceftazidime/avibactam · FAERS reaction fields

FAERS top-reaction field "Acute Kidney Injury" shows the widest count spread between ceftolozane/tazobactam and ceftazidime/avibactam in this extract (264-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect ceftolozane/tazobactam ceftazidime/avibactam
Death 81 -
Pathogen Resistance 54 -
Drug Resistance 30 -
Acute Kidney Injury 29 293
Incorrect Dose Administered 26 -
Pneumonia 26 294
Pancytopenia 25 -
Septic Shock 24 335

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

ceftolozane/tazobactam peer mix vs class inventory

Peer mix

0 OTC and 1 Rx SPL records in this peer set (1 total). Class inventory for Cephalosporin / Beta-Lactamase Inhibitor: 2 drugs.

Frequently Asked Questions

What same-class SPL records sit beside ceftolozane/tazobactam?
This registry lists 1 Cephalosporin / Beta-Lactamase Inhibitor medication records beside ceftolozane/tazobactam, including ceftazidime/avibactam. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide Cephalosporin / Beta-Lactamase Inhibitor peer set (1 records)

ceftolozane/tazobactam (Zerbaxa) sits in a wide Cephalosporin / Beta-Lactamase Inhibitor peer set (1 of 1 class peers shown). Labeled indication field for ceftolozane/tazobactam: Zerbaxa treats complicated infections in the stomach area and urinary tract.

Top FAERS reaction fields for ceftolozane/tazobactam total 342 reports across 10 reactions, set beside ceftazidime/avibactam. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full ceftolozane/tazobactam profile →

Field note for ceftolozane/tazobactam: see also the generic vs brand label guide when reading Zerbaxa SPL strings.